Blood pressure (BP) response to diuretics is varied in hypertensive patients. This study aimed to identify the patients who may respond better or worse to thiazide diuretics. Nondiabetic patients with treated or untreated hypertension were evaluated if they did not take diuretics and their office systolic BP (SBP) 4140 mm Hg or diastolic BP (DBP) 490 mm Hg. Diet and life style modification were advised in addition to the concomitant medication, if there were, for 2 weeks. Additional hydrochlorothiazide 50 mg was given per day for another 2 weeks. Both office and 24-h ambulatory BP were checked. The changes of office SBP were used for the response to thiazide treatment. A total of 92 patients were enrolled. Compared with those in the quartile of worst response, patients in the quartile of best response were older with increased baseline SBP and pulse pressure (PP) and reduced heart rate. Reduced baseline awake, but not increased sleep DBP was associated with better response to thiazide. Besides, baseline age, SBP and PP were correlated to the response to thiazide treatment. Among these variables, increased baseline mean BP independently predicted the best and reduced SBP predicted the worst responders. Accordingly, patients with higher mean BP respond better to thiazide treatment no matter with or without concomitant medication. Patients with mainly diastolic hypertension with lower SBP responded poorly to thiazide treatment. The findings may help to individualized use of thiazide in nondiabetic hypertensives.
Introduction
While the incidence continues to increase, 1 essential hypertension remains inadequately treated in the majority of patients. 2 It is not only in closely observed communities but also in carefully monitored antihypertensive drug trials 3 suggesting that more efficient antihypertensive strategies should be applied to clinical blood pressure (BP) control. Evidence from the Antihypertensive and LipidLowering to prevent Heart Attack Trial (ALLHAT) and other pivotal hypertension studies have established that thiazide-type diuretics confer significant reductions in stroke and cardiovascular events. [4] [5] [6] [7] [8] [9] [10] Although challenged by other agents, till date, thiazide diuretics remain one of the most widely recommended first-line therapy for hypertension. 11, 12 Given their strong record of evidence, low cost and favourable tolerability, low-dose thiazidetype diuretics are recommended as initial therapy in most hypertensive patients and are the foundation for multiple antihypertensive drug regimens according to the Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. 13 Though some particular patients have been suggested with better response to thiazide treatment, not all the patients with essential hypertension respond well to diuretics. 4, 5, 11 Some of them may even have elevated BP after short-term thiazide treatment. However, there is little information about the poor responder to thiazide treatment. On the other hand, thiazide diuretics, when used for a period of time, may impair glucose tolerance and metabolic profile and increase the onset of diabetes, gout and even hyponatremia in some particular patients. 14, 15 Thus, the use of thiazide diuretics should be properly evaluated and customized as a part of the clinical therapy in each individual patient. This study was then conducted to prospectively identify both the best and the worst responders to short-term thiazide treatment in a cohort of nondiabetic patients with treated or untreated essential hypertension. The findings may help for more individualized thiazide treatment at the customized basis.
Materials and methods

Study patients
Patients with essential hypertension were prospectively included if all the following criteria were fulfilled: (1) age between 25 and 65 years; (2) sitting office systolic BP (SBP) was 140-180 mm Hg and/or sitting diastolic BP (DBP) 90-110 mm Hg in three different occasions within a period of 3 months, or currently on X1 antihypertensive medications without any diuretics; (3) fasting plasma sugar o126 mg per 100 ml; (4) there was no evidence of secondary hypertension by serial studies including blood chemistry study, renal function test, endocrine examination, abdominal sonogram, renal arteriogram, and so on to exclude the possibility of chronic renal disease, renal arterial stenosis, primary aldosteronism, Cushing's syndrome, pheochromocytoma, thyroid disorder and coarctation of aorta. A written informed consent was given by the patient, and the study protocol has been approved in the ethic committee in Taipei VGH and Academic Sinica.
Patients with the following symptoms were excluded: (1) history of diabetes mellitus; (2) history of major systemic disease within recent 3 months; (3) body mass index 430 kg m À2 ; (4) renal dysfunction with plasma creatinin level 41.7 mg per 100 ml; (5) liver dysfunction with liver enzyme 42 times of the normal upper limit; (6) congestive heart failure with New York Heart association function class II-IV; (7) pregnant women.
Study design
All patients were first evaluated at the clinics of the hospital. A comprehensive history taking and physical check-up were conduct by doctors. All of them received a series of study including office BP, body mass index, waist and hip circumference, blood and urine sampling, 24-h ambulatory BP recording and electrocardiography. Patients were then instructed to avoid the heavy diet and keep normal salt intake as suggested by the research nurse. They were also asked, if possible, to measure and record their own BP in the morning hours at home. The patients were observed with their regular cardiovascular medications for two weeks.
When they returned to the clinics, the patients' BP was carefully measured by a well-trained nurse. Their eating habit was also monitored. If they had rechecked BP X140/90 mm Hg, they were assigned to take hydrochlorothiazide 50 mg once every morning for the next two weeks. SBP, DBP and mean arterial pressure were rechecked while the patients came back 2 weeks later to determine their response to thiazide treatment. Body weight and height were recorded in patients without shoes and wearing only light indoor clothes. Body mass index was defined as weight in kilograms divided by the square of height in metres. The waist circumference was measured midway between the iliac crest and the lowermost margin of the ribs. The hip circumference was measured at the maximum circumference of the buttocks, the subject standing with feet placed together. The waist-hip ratio was calculated as 100 Â (waist circumference in centimetre/hip circumference in centimetre).
Office BP measurement
At each visit, BP were measured by a well-trained nurse or assistant with an electronic BP monitor in the morning hours after sitting for 10 min in a quiet room. Three consecutive BP measurements were carried out each time. Each measurement was separated by a 30 s pulse measurement. BP were recorded as the average value of the last two recordings.
Ambulatory BP monitoring
In addition to conventional sphygmomanometry, all patients underwent 24-h ambulatory BP monitoring (ABPM). The device was an Oscar oscillometric ABPM (Sun Tech Medical Instruments, Eynsham Oxfordshire, UK). All patients were fitted with the device between 0800 and 1000 hours. The device was programmed to record BP every 15 min from 0600 to 2200 hours (awake BP) and every 30 min from 2200 to 0600 hours (sleep BP).
Laboratory measurements
Blood samples were obtained in the morning before eating and drug intake for analysis of blood urea nitrogen (BUN), creatinin (Cr), aspartate aminotransferase (AST) alanine aminotransferase (ALT), fasting blood glucose, total cholesterol (TC), triglyceride (TG), LDL-cholesterol, HDL-cholesterol and electrolytes (Na, K, Cl). Serum concentrations of BUN, Cr, AST, ALT, TC, TG and electrolytes were measured using a dry multilyser analytic slide method in the Fuji Dri-Chem 3000 analyser (Fuji Photo Film Corporation, Minato-Ku, Tokyo, Japan). Serum HDL-cholesterol levels were determined with an enzymatic cholesterol assay method after dextran sulphate precipitation. The plasma glucose concentration was determined by the glucose oxidase method on a Beckman Glucose Analyzer II (Beckman Instruments, Fullerton, CA, USA). Abbreviations: ACE, angiotensin converting enzyme; ALT, alanine aminotransferase ; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; BUN, blood urine nitrogen; BW, body weight; Cl, chloride; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; K, potassium; LDL-C, low-density lipoprotein cholesterol; Na, sodium; SBP, systolic blood pressure.
Statistical analysis
After the 2-week thiazide treatment, a significant reduction of office SBP (mean 7.47±9.66 mm Hg, Po0.05) was observed in the hypertensive patients. There were no significant changes in blood chemistry or metabolic profiles and no adverse events such as gout attack or hyponatremia during the treatment in the study group. However, the fasting blood sugar had increased to above 126 mg per 100 ml in three patients (3.3% of the all study patients) after the thiazide treatment. In two of the three patients, fasting blood sugar level was stable below 140 mg per 100 ml after thiazide diuretics were stopped. There was one patient requiring oral hypoglycaemic agents for his blood sugar control.
Responders according to the changes of office BP Patients were divided to four subgroups according to their response to thiazide treatment. The baseline characteristics of the patients in the best (best responders) and those in the worst (worst responders) quartiles were then compared. At baseline, the 23 best responders had significantly increased age, SBP and pulse pressure and reduced heart rate compared to the 23 worst responders (Table 1) . There was no significant difference in baseline concomitant antihypertensive medications between the best and the worst responders. Table 2 showed the baseline characteristics of the patients in the quartile of best response (best responders) vs patients in the other quartiles and of the patients in the quartile of worst response (worst responders) vs patients in the other quartiles. Compared to the other patients, the best responders were older and had higher baseline SBP, pulse pressure and mean artery pressure and lower heart rate. The biochemistry study and the concomitant antihypertensive medications were similar between the two groups. On the other hand, the worst responders had lower baseline SBP and pulse pressure than the others. The biochemistry study and the concomitant antihypertensive medications were also similar between the groups.
The best responders had more significant body weight decrease after thiazide treatment than the other patients (À1.04 ± 1.06 vs À0.34 ± 0.93 kgs, P ¼ 0.02). On the contrary, the worst responders had less body weight decrease after thiazide treatment when comparing to the other patients (À0.08±0.90 vs À0.66±1.00 kgs, P ¼ 0.034; Table 2 ). Compared to the worst responders, the best responders had significantly more body weight decrease after À1 , P ¼ 0.042). The latter may be related to the use of b-adrenergic blockers in patients already with antihypertensive medications. However, the SBP changes by thiazide diuretics were similar among patients without and those with one and those with two or more concomitant antihypertensive medications.
Ambulatory BP recording in responders
Among the 92 patients with thiazide treatment, there were 61 patients completing the 24-h ambulatory BP recording before thiazide treatment. The parameters of 24-h BP recordings were obtained from 17 of the total 23 patients with the best response and from 12 of the 23 patients with the worst response to thiazide treatment. Compared with the worst responders, the best responders had significantly less nocturnal fall of DBP (11.31±7.67 vs 18.19 ± 7.44%, P ¼ 0.024) and tended to have less awake DBP (90.61 ± 7.15 vs 95.57 ± 10.60 mm Hg, P ¼ 0.065) and less nocturnal fall of SBP (10.35±6.55 vs 14.93±6.15%, P ¼ 0.065). The data were further compared among the patients with the upper, middle and lower third response in office SBP reduction to thiazide treatment (Table 3 ). The SBP changes by thiazide significantly differed among the three groups. Baseline awake DBP was lower in patients with the upper third response to thiazide than that in other patients (P ¼ 0.050).
Correlations between the baseline parameters and BP changes in response to thiazide treatment In the whole study cohort, age of the patients was correlated to the SBP changes with thiazide treatment (g ¼ 0.220, P ¼ 0.035; Figure 1 ). Baseline office SBP and pulse pressure were also correlated to the changes of SBP (g ¼ 0.308, P ¼ 0.003; g ¼ 0.331; P ¼ 0.001, respectively; Figures 2 and 3 ). The data indicated that patients with older age, and higher office SBP and pulse pressure at baseline had more reduction in office SBP by thiazide treatment.
Independent predictors for the best and the worst responders to thiazide treatment Further investigation with multivariate forward stepwise logistic regression showed that baseline office mean artery pressure was the independent predictor for the best response (OR, 1.049; 95% CI, 1.000-1.101; P ¼ 0.049) and baseline office SBP was the independent predictor for the worst response to thiazide treatment (OR, 0.954; 95% CI, 0.912-0.998; P ¼ 0.039; Table 4 ). The data indicated that increased baseline mean BP and decreased SBP were the most important predictors for the best and worst responses of short-term thiazide treatment in a cohort of nondiabetic patients with treated or untreated essential hypertension. Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.
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Discussion
It has been indicated that in patients with essential hypertension, a relatively expanded blood volume could be involved in the maintenance of hypertension even if the absolute value might be reduced. 16, 17 In these patients, BP could be reduced by reduction of body sodium and fluid with salt restriction or diuretics administration. In the present study, to avoid the BP effect of absolute blood volume accumulation and excessive salt retention, normal salt diet and life-style modification were advised to each patient for 2 weeks before thiazide was given. Indeed, 60 (39.5%) of the 152 patients initially evaluated were excluded due to the normalization of BP after 2-week diet and life-style modification in addition to their concomitant medications, if there were any. It is then possible to prospectively identify both a subgroup of patients who particularly respond to thiazide and so are called the 'best responders', and another subgroup of patients with significantly poor response and so are called the 'worst responders,' simultaneously in the current study.
In the present study, the patients responding well to short-term thiazide diuretics had relatively increased office SBP, mean BP and pulse pressure, and reduced baseline heart rate before thiazide treatment. Given that cardiac output is the major contributor to SBP, the volume reduction by thiazide diuretics might reduce SBP in some of these patients. 11 While the baseline body weight, serum sodium and chloride levels were similar between the groups, body weight was more reduced by thiazide treatment in the best responders than in the other patients, suggesting that these hypertensive patients, rather than others, could be particularly sensitive to the volume reduction as well as diuretic effect of thiazide no matter other antihypertensive agents have been given or not. 
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It has been suggested that diuretics could, by reducing intravascular blood or fluid accumulation, reduce venous return of blood during supine position at night, which may effectively decrease nocturnal BP in untreated hypertensive patients without nocturnal fall of BP and so is called nondipper hypertension, a risk factor of future cardiovascular events. [18] [19] [20] However, in the present study, patients with lower awake rather than those with increased sleep DBP at baseline may have better BP reduction by short-term thiazide treatment, suggesting the potential role of daytime rather than night-time BP for blunting diurnal BP changes in these patients. Future study may be indicated to evaluate the effect of thiazide diuretics on nocturnal BP for restoration of normal circadian BP changes in patients already under other antihypertensive medications.
In the present study, official SBP was used as the main parameter to assess the effects of thiazide diuretics in hypertensive patients. This is partly due to that SBP is almost always less well controlled than DBP 21 even in large clinical trials. 22, 23 More importantly, SBP is suggested as a much better predictor of target organ damage and future cardiovascular and renal events than DBP. 24, 25 In the present study, age, baseline SBP and pulse pressure were positively correlated to the effects of SBP reduction by thiazide treatment, suggesting the possible early presence of increased stiffness of large arteries even in a cohort of mainly middle-aged hypertensives. 26, 27 Accordingly, thiazide diuretics either alone or in combination may have particular beneficial effects not only on elderly patients 28, 29 but also on younger patients with increased arterial or aortic stiffness as that shown in the present study.
Recent evidence has indicated the role of baseline BP indices including SBP, DBP, mean BP and pulse pressure in the prediction of target organ damage and future cardiovascular and cerebrovascular events. 24, 25, [30] [31] [32] However, their role in the prediction of BP response to thiazide treatment had not been well defined before. Among these indices, SBP and mean BP, rather than DBP and pulse pressure, could be more predictive for future cardiovascular events, particularly stroke, in both hypertensive and normotensive subjects, in both young and old hypertensives and in both Western and Asian population. [30] [31] [32] The findings of our study further indicated that increased mean BP could independently predict the best responder and decreased SBP could predict the worst responder to thiazide treatment. Taking the above together, one may recognize the impacts of baseline SBP as well as mean BP not only to the response to thiazide treatment but also to the future target organ damage and clinical events. It could be of particular clinical importance. While not all the hypertensive patients, either treated or untreated, may benefit from thiazide treatment, as that shown in the present study, some BP indices such as baseline SBP and mean BP could help to identify those patients who may or may not be treated with thiazide diuretics for their potential future benefits.
In fact, in the present study, 60% of the patients may have more or less SBP reduction by short-term thiazide treatment. We further identified the particular quarter of the patients, the 'best responders,' who may benefit much more than the others from the thiazide diuretics. Thiazide diuretics should never be forgotten in these patients. On the other hand, there was no significant BP reduction or even elevation after thiazide in up to 20% of the patients. More importantly, three patients developed newonset diabetes mellitus after the 2-week thiazide treatment in this study. It is then critical to find out the patients who might respond minimal to thiazide diuretics, the 'worst responders,' before the treatment. In such patients, thiazide should be better weaved to avoid its unnecessary side effects.
There were some limitations in the present study. Firstly, thiazide was given only for 2 weeks. We could not exclude the possibility that some of the patients may have late response to thiazide treatment. However, the acute antihypertensive effects of thiazide could be established by its diuretic effects within 5-7 days of the treatment. After then, an additional mild vasodilatation effect of thiazide would develop progressively. 33 In the present study, mainly the diuretic effects of thiazide on BP were evaluated. Future study for the chronic antihypertensive effects of prolonged thiazide treatment may be considered. Secondly, both patients with or without concomitant antihypertensive agents were enrolled in this study. In the real world, combined therapy is indicated for most of the hypertensive patients. 4, 6, 13 It is important but scanty studies could have been conducted to evaluate the add-on effects of thiazide in patients already on other antihypertensive
What is known about topic K Blood pressure (BP) response to thiazide diuretics, the first-line choice of antihypertensive treatment, might be significantly varied in individual hypertensive patient. K It was suggested that elderly patients and nondippers are prone to be salt sensitive and might have better response to thiazide diuretics. K There is little information about the poor responders to thiazide treatment.
What this study adds K Both the clinical characteristics of the best and that of the worst responders to thiazide diuretics were prospectively and simultaneously identified in a cohort of middle-aged hypertensive patients. K Hypertensive patients with higher baseline office systolic BP, mean BP, pulse pressure, or lower awake but not increased sleep diastolic BP may respond better to thiazide diuretics no matter they are taking other antihypertensive agents or not. K Patients with mainly diastolic hypertension and relatively normal office systolic BP and pulse pressure might respond poorly to thiazide treatment.
agents. Finally, only hypertensive patients without diabetes mellitus were enrolled in this study.
Further studies in diabetic patients may be also required. Accordingly, thiazide diuretics may be used on customized basis. Hypertensive patients with relatively old age, higher baseline mean BP and lower awake but not increased sleep DBP may have better response to thiazide diuretics no matter whether they are taking other antihypertensive agents or not. On the other hand, patients with mainly diastolic hypertension with relatively lower SBP might respond poorly to thiazide treatment. It should be better avoided in these patients.
